Skip to main content
Log in

Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Peroxisome proliferators-activated receptor γ (PPARγ) is a nuclear hormone receptor that serves as a master regulator for adipocytes-specific genes contributing to adipocytes differentiation, insulin sensitivity and lipid metabolism. The substitution of proline to alanine at codon 12 of the PPAR γ2 gene (Pro12Ala polymorphism) is most widely studied, and the associations with diabetes, obesity, and other clinical parameters have been reported and discussed in several ethnic groups. Among native Qatar ethnicity, however, there is no report about this polymorphism. The aim of this study was to estimate the allele frequency of the Pro12Ala polymorphism of PPAR γ2 gene among Qatari population and investigate the association between this polymorphism and obesity or type 2 diabetes. This is a matched case–control study. It was carried out among diabetic patients and healthy subjects at the Primary Healthcare Clinics, and the survey was conducted from February 2003 to March 2006 in Qatari male and female nationals aged 35 to 60 years. The study was based on matched age, sex, and ethnicity of 400 cases (with diabetes) and 450 controls (without diabetes). Face-to-face interviews were based on a questionnaire that included variables such as age, sex, sociodemographic status, body mass index (BMI), and obesity. Their health status was assessed by medical conditions, family history, and blood pressure measurements. The allele frequency of Pro12Ala polymorphism in PPAR γ2 gene among Qataris is lower than that in many Caucasian ethnic groups. No association is seen between the Pro12Ala and type 2 Diabetes (0.055 vs 0.059, OR = 1.1311, P = 0.669). Nearly half of the diabetic type 2 patients (48.5%) were obese (BMI > 30) compared to nondiabetic subjects (29.8%) (P < 0.001). In this study, no association is seen between the Pro12Ala polymorphism in PPAR γ2 gene and the type2 diabetes in Qatar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R (2003) Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228:1111–1117

    CAS  Google Scholar 

  2. Stumvoll M, Haring H (2002) Perspective in diabetes: The peroxisome proliferators-activated receptor γ2 Pro12Ala polymorphism. Diabetes 50:2341–2347

    Article  Google Scholar 

  3. Barroso I, Gurnell M, Crowley VEF et al (1999) Dominant negative mutations in human PPAR γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402(6764):880–883

    PubMed  CAS  Google Scholar 

  4. Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K (2005) A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia. Diabetes Metab Res Rev 21:465–469

    Article  PubMed  CAS  Google Scholar 

  5. Tavares V, Hirata RD, Rodrigues AC, Monte O, Salles JE, Scalissi N, Speranza AC, Hirata MH (2005) Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. Diabetes Obes Metab 7:605–611

    Article  PubMed  CAS  Google Scholar 

  6. Giusti V, Verdumo C, Sutter M, Gaillard RC, Burckhardt P, Pralong F (2003) Expression of PPAR γ 2 in visceral and subcutaneous adipose tissue of obese women. Diabetes 52:1673–1676

    Article  PubMed  CAS  Google Scholar 

  7. Fajas L, Auboeuf D, Raspe E et al (1997) The organization, promoter analysis, and expression of the human PPAR γ gene. J Biol Chem 272:18779–18789

    Article  PubMed  CAS  Google Scholar 

  8. Bener A, Zirie M, Al-Rikabi R (2005) Genetics, obesity and environmental risk factors associated with type 2 diabetes. Croat Med J 46:302–307

    PubMed  Google Scholar 

  9. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P (2005) Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 6:11

    Article  PubMed  Google Scholar 

  10. Deeb SS, fajas L, Nemoto M et al (2004) A Pro12Ala substitution in PPAR γ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287

    Article  Google Scholar 

  11. Frederiksen L, Broadbaek K, Fenger M et al (2002) Comment: studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 87:3989–3992

    Article  PubMed  CAS  Google Scholar 

  12. Mori H, Ikegami H, Kawaguchi Y et al (2001) Brief genetics report the Pro12 → Ala substitution in PPAR γ is associated with resistance to development of diabetes in the general population possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50:891–894

    Article  PubMed  CAS  Google Scholar 

  13. Altshuler D, Hirschhorn JN, Klannenmark M et al (2000) The common PPAR Pro12ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80

    Article  PubMed  CAS  Google Scholar 

  14. Masud S, Ye S, SAS group (2003) Effect of the peroxisome proliferators activated receptor γ2 Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40:773–780

    Article  PubMed  CAS  Google Scholar 

  15. Beamer BA, Yen C-J, Andersen RE et al (1998) Brief genetics report: association of the Pro12Ala variant in the PPAR γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806–1809

    Article  PubMed  CAS  Google Scholar 

  16. Tai ES, Corella D, Yap MD et al (2004) Differential effects of the C1431T and Pro12Ala PPAR γ2 variants on plasma lipids and diabetes risk in an Asian population. J Lipids Res 45:674–685

    Article  CAS  Google Scholar 

  17. Oh EY, Min KM, Chung JH et al (2000) Significance of Pro12Ala mutation in peroxisome proliferators-activated receptor γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801–1804

    Article  PubMed  CAS  Google Scholar 

  18. Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier LJ (2003) A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes 52:1864–1871

    Article  PubMed  Google Scholar 

  19. Rosmond R, Chagnon M, Bouchard C (2003) The Pro12Ala PPAR γ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab Res Rev 19:159–163

    Article  PubMed  CAS  Google Scholar 

  20. Sanchez JLG, Rios MS, Perez CF, Laakso M, larrad MTM (2002) Effect of the Pro12Ala polymorphism of the peroxisome proliferators activated receptor γ 2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. J Eur Endocrinol 147:495–501

    Article  CAS  Google Scholar 

  21. American Diabetes Association (2004) Diagnosis classification of diabetes mellitus. Diabetes Care 27:S5–S10

    Article  Google Scholar 

  22. World Health Organization (1999) International society of hypertension guidelines for the management of hypertension. J Hypertens 17:151–182

    Google Scholar 

  23. Stumvoll M, Haring H (2002) Perspectives in diabetes: the peroxisome proliferator–activated receptor-γ 2 Pro12Ala polymorphism. Diabetes 51:2341–2347

    Article  PubMed  CAS  Google Scholar 

  24. de Pablos-Velasco PL, Martinez-Martin FJ, Rodriguez-Perez A et al (2001) Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population comparison of the 1997 ADA and the 1985 WHO criteria. The Guia study. Diabet Med 18:235–341

    Article  PubMed  Google Scholar 

  25. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MIJ (2001) Effect of the Pro12Ala polymorphism of the PPAR γ2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 44:925–926

    Article  PubMed  CAS  Google Scholar 

  26. Hasstedt SJ, Ren Q-F, teng K, Elbein SC (2001) Effect of the peroxisome proliferators-activated receptor-γ2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial Type2 diabetic kindreds. J Clin Endocrinol Metab 86:536–541

    Article  PubMed  CAS  Google Scholar 

  27. Luan J, Browne PO, Harding AH et al (2001) Evidence for gene-nutrient interaction at the PPAR γ locus. Diabetes 50:686–689

    Article  PubMed  CAS  Google Scholar 

  28. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A et al (2003) Peroxisome proliferators-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 21:1649–1655

    Article  PubMed  CAS  Google Scholar 

  29. Zouari Bouassida K, Chouchane L, Jellouli K, Cherif S, Haddad S, Gabbouj S, Danguir J (2005) The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients. Diabetes Metab 31:119–23

    Article  PubMed  CAS  Google Scholar 

  30. Sutanegara D, Darmono, Budhiarta AAG (2000) The epidemiology and management of diabetes mellitus in Indonesia. Diabetes Res Clin Pract 50(Suppl 2):S9–S16

    Article  PubMed  Google Scholar 

  31. Bener A, Alali KA (2006) Consanguineous marriage in a newly developed country: the Qatari population. J Biosoc Sci 38:239–246

    Article  PubMed  Google Scholar 

  32. Bener A, Hussain R (2006) Consanguineous unions and child health in Qatar. Paediatr Perinat Epidemiol 20:372–378

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The project was supported and funded by Hamad Medical Corporation (HMC) Grant No. 231. We would like to thank Hamad Medical Corporation and Diabetic Association for generous support and help while this project was conducted. We also thank the technical staff of the Molecular Genetics Laboratory of the HMC for their technical contribution to this study, in particular, Aisha Al-Khelaifi, Ali Alavi, Mashael Al-Jaber, and Irene D’Souza.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abdulbari Bener.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Badii, R., Bener, A., Zirie, M. et al. Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol 45, 15–21 (2008). https://doi.org/10.1007/s00592-007-0013-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-007-0013-8

Keywords

Navigation